EUVIMED · CrossrefJournal
mAbs
ISSN 1942-0862 · Informa UK Limited
Latest articles
Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection
Conformation-aware structure prediction of antigen-recognizing immune proteins
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells
Structure-guided design of antibody CDRs to reduce their reactivity to treatment-emergent anti-drug antibodies
Multidimensional maturation of antibody variable domains with machine-learning assistance
The making of multispecific immunoglobulins – a clinical perspective
Antibodies to watch in 2026
Systematic review and data-driven insights into CHO cell engineering for next-generation antibody production
Rapid and selective characterization of antibody-drug conjugates in complex sample matrices by native affinity liquid chromatography-mass spectrometry
Expanding the horizons of cancer therapy with next-generation 4-1BB agonists: a review of molecular and clinical strategies to maximize efficacy and ensure safety
Alpseq : an open-source workflow to turbocharge nanobody discovery with high-throughput sequencing
Dual agonism and selective T-cell depletion activity of a PD-1-directed antibody for treating autoimmune diseases
NAStructuralDB : structural database to facilitate computational studies of molecular modeling and recognition of proteins with special focus on antibody–antigen interactions
A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO
Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma
Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy
Impact of process parameters on IgG glycosylation in CHO systems: a comprehensive quantitative analysis
Using mass spectrometry for robust identity release testing in a global quality control network
Correction
AbDist: a lightweight, distance-based model for antibody affinity prediction as an interpretable benchmark for machine learning models
Tokenizing loops of antibodies
Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates
Mannose receptor contributes to preferential oligomannosidic glycoform clearance in a murine pharmacokinetics model
Impact of afucosylation strategy on antibody function: a comparative study of glycoengineered anti-CD20 antibodies Obinutuzumab and Obinutuzumab beta
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis
Engineering of acidic pH-responsive anti-CD3 binding antibodies
Targeting IL-7Rα with PNU-159682 antibody–drug conjugates in acute lymphoblastic leukemia: translational implications
Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties
Population-level analysis of glycoprotein glycoforms
A novel insulin-like growth factor II-based masking domain for conditional activation of therapeutic antibodies
EUVIMED